219 related articles for article (PubMed ID: 28973947)
1. Semisynthetic glycoconjugate vaccine candidate against
Lisboa MP; Khan N; Martin C; Xu FF; Reppe K; Geissner A; Govindan S; Witzenrath M; Pereira CL; Seeberger PH
Proc Natl Acad Sci U S A; 2017 Oct; 114(42):11063-11068. PubMed ID: 28973947
[TBL] [Abstract][Full Text] [Related]
2. A semisynthetic
Schumann B; Hahm HS; Parameswarappa SG; Reppe K; Wahlbrink A; Govindan S; Kaplonek P; Pirofski LA; Witzenrath M; Anish C; Pereira CL; Seeberger PH
Sci Transl Med; 2017 Mar; 9(380):. PubMed ID: 28275152
[TBL] [Abstract][Full Text] [Related]
3. Improving vaccines against
Kaplonek P; Khan N; Reppe K; Schumann B; Emmadi M; Lisboa MP; Xu FF; Calow ADJ; Parameswarappa SG; Witzenrath M; Pereira CL; Seeberger PH
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13353-13358. PubMed ID: 30530654
[No Abstract] [Full Text] [Related]
4. A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease.
Emmadi M; Khan N; Lykke L; Reppe K; G Parameswarappa S; Lisboa MP; Wienhold SM; Witzenrath M; Pereira CL; Seeberger PH
J Am Chem Soc; 2017 Oct; 139(41):14783-14791. PubMed ID: 28945368
[TBL] [Abstract][Full Text] [Related]
5. Sequential Linkage of Carbohydrate Antigens to Mimic Capsular Polysaccharides: Toward Semisynthetic Glycoconjugate Vaccine Candidates against
Seco BMS; Xu FF; Grafmüller A; Kottari N; Pereira CL; Seeberger PH
ACS Chem Biol; 2020 Sep; 15(9):2395-2405. PubMed ID: 32835479
[TBL] [Abstract][Full Text] [Related]
6. Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against
Schumann B; Reppe K; Kaplonek P; Wahlbrink A; Anish C; Witzenrath M; Pereira CL; Seeberger PH
ACS Cent Sci; 2018 Mar; 4(3):357-361. PubMed ID: 29632881
[TBL] [Abstract][Full Text] [Related]
7. Deciphering Antigenic Determinants of Streptococcus pneumoniae Serotype 4 Capsular Polysaccharide using Synthetic Oligosaccharides.
Geissner A; Pereira CL; Leddermann M; Anish C; Seeberger PH
ACS Chem Biol; 2016 Feb; 11(2):335-44. PubMed ID: 26674834
[TBL] [Abstract][Full Text] [Related]
8. Semisynthetic Glycoconjugate Vaccines To Elicit T Cell-Mediated Immune Responses and Protection against
Feng S; Xiong C; Wang S; Guo Z; Gu G
ACS Infect Dis; 2019 Aug; 5(8):1423-1432. PubMed ID: 31126171
[No Abstract] [Full Text] [Related]
9. Synthesis and delivery of
Su H; Liu Q; Bian X; Wang S; Curtiss R; Kong Q
Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33380455
[No Abstract] [Full Text] [Related]
10. Chemical Synthesis Elucidates the Immunological Importance of a Pyruvate Modification in the Capsular Polysaccharide of Streptococcus pneumoniae Serotype 4.
Pereira CL; Geissner A; Anish C; Seeberger PH
Angew Chem Int Ed Engl; 2015 Aug; 54(34):10016-9. PubMed ID: 26212109
[TBL] [Abstract][Full Text] [Related]
11. Chimeric oligosaccharide conjugate induces opsonic antibodies against
Sanapala SR; Seco BMS; Baek JY; Awan SI; Pereira CL; Seeberger PH
Chem Sci; 2020 Jun; 11(28):7401-7407. PubMed ID: 34123020
[No Abstract] [Full Text] [Related]
12. Identification of the Minimal Glycotope of Streptococcus pneumoniae 7F Capsular Polysaccharide using Synthetic Oligosaccharides.
Ménová P; Sella M; Sellrie K; Pereira CL; Seeberger PH
Chemistry; 2018 Mar; 24(16):4181-4187. PubMed ID: 29333751
[TBL] [Abstract][Full Text] [Related]
13. Structural, Biosynthetic, and Serological Cross-Reactive Elucidation of Capsular Polysaccharides from Streptococcus pneumoniae Serogroup 16.
Li C; Duda KA; Elverdal PL; Skovsted IC; Kjeldsen C; Duus JØ
J Bacteriol; 2019 Oct; 201(20):. PubMed ID: 31383737
[TBL] [Abstract][Full Text] [Related]
14. A semisynthetic glycoconjugate provides expanded cross-serotype protection against Streptococcus pneumoniae.
Kaplonek P; Yao L; Reppe K; Voß F; Kohler T; Ebner F; Schäfer A; Blohm U; Priegue P; Bräutigam M; Pereira CL; Parameswarappa SG; Emmadi M; Ménová P; Witzenrath M; Hammerschmidt S; Hartmann S; Sander LE; Seeberger PH
Vaccine; 2022 Feb; 40(7):1038-1046. PubMed ID: 35033388
[
